BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AZD0754 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AZD0754\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06267729-11145@assetmemo.bio
DTSTAMP:20261121T004029Z
DTSTART;VALUE=DATE:20261124
DTEND;VALUE=DATE:20261125
SUMMARY:AZD0754: Phase 1/2 readout est. (NCT06267729)
DESCRIPTION:AZD0754\, phase 1/2\, Prostate Cancer.\nStudy: Study of AZD0754
  in Participants With Metastatic Prostate Cancer\nEstimated primary comple
 tion: 24 November 2026. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/azd0754#upcoming-events\nRegistry record: https://clinicaltrials.gov/st
 udy/NCT06267729
URL:https://assetmemo.bio/drug/azd0754#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
